CoChat

A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina

Open access
Chaffiol, Antoine, Caplette, Romain, Jaillard, Céline, Brazhnikova, Elena, Desrosiers, Mélissa, Dubus, Elisabeth, Duhamel, Laëtitia, Macé, Emilie, Marre, Olivier, Benoit, Patrick, Hantraye, Philippe, Bemelmans, Alexis-Pierre, Bamberg, Ernst, Duebel, Jens, Sahel, José-Alain, Picaud, Serge, Dalkara, Deniz · 2017 · Molecular Therapy
Cited by 152

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The majority of inherited retinal degenerations converge on the phenotype of photoreceptor cell death. Second- and third-order neurons are spared in these diseases, making it possible to restore retinal light responses using optogenetics. Viral expression of channelrhodopsin in the third-order neurons under ubiquitous promoters was previously shown to restore visual function, albeit at light intensities above illumination safety thresholds. Here, we report (to our knowledge, for the first time) activation of macaque retinas, up to 6 months post-injection, using channelrhodopsin-Ca 2+ -permeable channelrhodopsin (CatCh) at safe light intensities. High-level CatCh expression was achieved due to a new promoter based on the regulatory region of the gamma-synuclein gene (SNCG) allowing strong expression in ganglion cells across species. Our promoter, in combination with clinically proven adeno-associated virus 2 (AAV2), provides CatCh expression in peri-foveolar ganglion cells responding robustly to light under the illumination safety thresholds for the human eye. On the contrary, the threshold of activation and the proportion of unresponsive cells were much higher when a ubiquitous promoter (cytomegalovirus [CMV]) was used to express CatCh. The results of our study suggest that the inclusion of optimized promoters is key in the path to clinical translation of optogenetics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2017.07.011

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 39

  1. Bessant, 2001, Molecular genetics and prospects for therapy of the inherited retinal dystrophies, Curr. Opin. Genet. Dev., 11, 307, 10.1016/S0959-437X(00)00195-7 · DOI
  2. Wright, 2010, Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait, Nat. Rev. Genet., 11, 273, 10.1038/nrg2717 · DOI · Paper page
  3. Humayun, 1999, Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa, Invest. Ophthalmol. Vis. Sci., 40, 143
  4. Jacobson, 2013, Retinal optogenetic therapies: clinical criteria for candidacy, Clin. Genet., 84, 175, 10.1111/cge.12165 · DOI
  5. Lorach, 2015, Photovoltaic restoration of sight with high visual acuity, Nat. Med., 21, 476, 10.1038/nm.3851 · DOI · Paper page
  6. Bi, 2006, Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration, Neuron, 50, 23, 10.1016/j.neuron.2006.02.026 · DOI · Paper page
  7. Lagali, 2008, Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration, Nat. Neurosci., 11, 667, 10.1038/nn.2117 · DOI · Paper page
  8. Greenberg, 2011, Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism, Neuron, 69, 713, 10.1016/j.neuron.2011.01.024 · DOI
  9. Pan, 2014, ChR2 mutants at L132 and T159 with improved operational light sensitivity for vision restoration, PLoS ONE, 9, e98924, 10.1371/journal.pone.0098924 · DOI
  10. Busskamp, 2010, Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa, Science, 329, 413, 10.1126/science.1190897 · DOI · Paper page
  11. Tomita, 2010, Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats, Exp. Eye Res., 90, 429, 10.1016/j.exer.2009.12.006 · DOI · Paper page
  12. Gaub, 2014, Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells, Proc. Natl. Acad. Sci. USA, 111, E5574, 10.1073/pnas.1414162111 · DOI · Paper page
  13. Sengupta, 2016, Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina, EMBO Mol. Med., 8, 1248, 10.15252/emmm.201505699 · DOI · Paper page
  14. Doroudchi, 2011, Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness, Mol. Ther., 19, 1220, 10.1038/mt.2011.69 · DOI · Paper page
  15. Tomita, 2014, Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1, Mol. Ther., 22, 1434, 10.1038/mt.2014.81 · DOI · Paper page
  16. Macé, 2015, Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice, Mol. Ther., 23, 7, 10.1038/mt.2014.154 · DOI · Paper page
  17. Busskamp, 2011, Optogenetic approaches to restoring visual function in retinitis pigmentosa, Curr. Opin. Neurobiol., 21, 942, 10.1016/j.conb.2011.06.001 · DOI
  18. Cideciyan, 2008, Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics, Proc. Natl. Acad. Sci. USA, 105, 15112, 10.1073/pnas.0807027105 · DOI · Paper page
  19. Vandenberghe, 2011, Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey, Sci. Transl. Med., 3, 88ra54, 10.1126/scitranslmed.3002103 · DOI · Paper page
  20. Ramachandran, 2017, Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina, Hum. Gene Ther., 28, 154, 10.1089/hum.2016.111 · DOI · Paper page
  21. Sugano, 2011, Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy, Gene Ther., 18, 266, 10.1038/gt.2010.140 · DOI
  22. Ivanova, 2010, Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina, Invest. Ophthalmol. Vis. Sci., 51, 5288, 10.1167/iovs.10-5389 · DOI · Paper page
  23. Bennett, 2012, AAV2 gene therapy readministration in three adults with congenital blindness, Sci. Transl. Med., 4, 120ra15, 10.1126/scitranslmed.3002865 · DOI · Paper page
  24. Kleinlogel, 2011, Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh, Nat. Neurosci., 14, 513, 10.1038/nn.2776 · DOI · Paper page
  25. Surgucheva, 2008, Gamma-synuclein as a marker of retinal ganglion cells, Mol. Vis., 14, 1540
  26. Quina, 2005, Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways, J. Neurosci., 25, 11595, 10.1523/JNEUROSCI.2837-05.2005 · DOI · Paper page
  27. Allen, 2017, Melanopsin contributions to the representation of images in the early visual system, Curr. Biol., 27, 1623, 10.1016/j.cub.2017.04.046 · DOI · Paper page
  28. Nussenblatt, 1985, Standardization of vitreal inflammatory activity in intermediate and posterior uveitis, Ophthalmology, 92, 467, 10.1016/S0161-6420(85)34001-0 · DOI · Paper page
  29. Jabs, 2005, Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop, Am. J. Ophthalmol., 140, 509, 10.1016/j.ajo.2005.03.057 · DOI · Paper page
  30. Nagel, 2003, Channelrhodopsin-2, a directly light-gated cation-selective membrane channel, Proc. Natl. Acad. Sci. USA, 100, 13940, 10.1073/pnas.1936192100 · DOI · Paper page
  31. Kleinlogel, 2011, A gene-fusion strategy for stoichiometric and co-localized expression of light-gated membrane proteins, Nat. Methods, 8, 1083, 10.1038/nmeth.1766 · DOI
  32. Izpisua Belmonte, 2015, Brains, genes, and primates, Neuron, 86, 617, 10.1016/j.neuron.2015.03.021 · DOI · Paper page
  33. Byrne, 2015, Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration, J. Clin. Invest., 125, 105, 10.1172/JCI65654 · DOI · Paper page
  34. Wu, 2006, Photochemical damage of the retina, Surv. Ophthalmol., 51, 461, 10.1016/j.survophthal.2006.06.009 · DOI · Paper page
  35. Lin, 2013, ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation, Nat. Neurosci., 16, 1499, 10.1038/nn.3502 · DOI · Paper page
  36. van Wyk, 2015, Restoring the ON switch in blind retinas: Opto-mGluR6, a next-generation, cell-tailored optogenetic tool, PLoS Biol., 13, e1002143, 10.1371/journal.pbio.1002143 · DOI · Paper page
  37. Gaub, 2015, Optogenetic vision restoration using rhodopsin for enhanced sensitivity, Mol. Ther., 23, 1562, 10.1038/mt.2015.121 · DOI · Paper page
  38. Choi, 2007, Production of recombinant adeno-associated viral vectors, Curr. Protoc. Mol. Biol., Chapter 12
  39. Aurnhammer, 2012, Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences, Hum. Gene Ther. Methods, 23, 18, 10.1089/hgtb.2011.034 · DOI · Paper page

Cited by

See all 152

Metadata

Authors
Chaffiol, A., Caplette, R., Jaillard, C., Brazhnikova, E., Desrosiers, M., Dubus, E., Duhamel, L., Macé, E., Marre, O., Benoit, P., Hantraye, P., Bemelmans, A.-P., Bamberg, E., Duebel, J., Sahel, J.-A., Picaud, S., & Dalkara, D.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2017-11
Volume
25
Issue
11
Pages
2546-2560
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2738256613
Cited by
152
References
15
FWCI
7.28
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • Sanofi
  • INSERM
  • UPMC
  • CNRS
  • Fondation pour la Recherche Medicale
  • Agence Nationale pour la Recherche Investissements d’Avenir Recherche Hospitalo-Univesritaire en santé
  • RHU
  • E-Rare Project
  • OPTOREMODE
  • Foundation Fighting Blindness (TA-GT-0911-0543-UPMC-WG)
  • Fédération des Aveugles de France
  • City of Paris
  • Regional Council of Ile-de-France
  • Agence Nationale de la Recherche (ANR-10-LABX-65)
  • European Research Council
  • ERC (309776)
  • Deutsche Forschungsgemeinschaft (SFB 807)
  • Max Planck Society
  • NIH (U01NS090501)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina. https://app.cochat.ai/papers/10.1016/j.ymthe.2017.07.011
The paper
Chaffiol, A., Caplette, R., Jaillard, C., Brazhnikova, E., Desrosiers, M., Dubus, E., Duhamel, L., Macé, E., Marre, O., Benoit, P., Hantraye, P., Bemelmans, A.-P., Bamberg, E., Duebel, J., Sahel, J.-A., Picaud, S., & Dalkara, D. (2017). A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2017.07.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.